TD Ameritrade Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
TD Ameritrade Investment Management's EW Position: Q3 2023 in Review
TD Ameritrade Investment Management sold out of Edwards Lifesciences (EW) in Q3 2023, closing a stake of 395 shares — an estimated $37K sold.
TD Ameritrade Investment Management first reported a position in EW in Q1 2019 and held it in 17 quarters. The position peaked at $37K in Q2 2023. 1,219 funds tracked by Wall St. Rank hold EW as of Q3 2023.
- TD Ameritrade Investment Management reported no remaining Edwards Lifesciences position as of Q3 2023 after selling out during the quarter.
- TD Ameritrade Investment Management sold 395 Edwards Lifesciences shares in Q3 2023, an estimated $37K.
- TD Ameritrade Investment Management first reported a position in Edwards Lifesciences in Q1 2019 and held it in 17 quarters.
- TD Ameritrade Investment Management's Edwards Lifesciences position peaked at $37K in Q2 2023.
- 1,219 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.
Based on TD Ameritrade Investment Management's 13F filing for Q3 2023.